Parameters | Myricetin | Epigallocatechin gallate | Curcumin | Kaempferol |
---|---|---|---|---|
LogS | -3.665 | -3.805 | -3.921 | -3.624 |
LogD | 0.9 | 1.058 | 2.82 | 2.233 |
LogP | 1.747 | 1.862 | 2.742 | 2.656 |
Pgp-Inhibitor | 0.004 | 0.019 | 0.284 | 0.004 |
Pgp-Substrate | 0.006 | 0 | 0.014 | 0.011 |
HIA | 0.035 | 0.914 | 0.06 | 0.008 |
F(20%) | 0.977 | 0.999 | 0.011 | 0.856 |
F(30%) | 0.999 | 1 | 0.171 | 0.993 |
Caco-2 | -5.653 | -6.608 | -4.834 | -4.974 |
MDCK | 6.38E-06 | 4.56E-06 | 1.63E-05 | 9.07E-06 |
BBB | 0.006 | 0.006 | 0.103 | 0.009 |
PPB | 92.77% | 87.88% | 99.80% | 97.86% |
VDss | 0.633 | 0.521 | 0.369 | 0.522 |
Fu | 10.35% | 8.26% | 1.05% | 4.41% |
CYP1A2-Inhibitor | 0.846 | 0.239 | 0.593 | 0.972 |
CYP1A2-Substrate | 0.108 | 0.071 | 0.758 | 0.11 |
CYP2C19-Inhibitor | 0.027 | 0.026 | 0.287 | 0.181 |
CYP2C19-Substrate | 0.037 | 0.035 | 0.12 | 0.046 |
CYP2C9-Inhibitor | 0.574 | 0.566 | 0.661 | 0.653 |
CYP2C9-Substrate | 0.32 | 0.204 | 0.906 | 0.867 |
CYP2D6-Inhibitor | 0.098 | 0.013 | 0.037 | 0.722 |
CYP2D6-Substrate | 0.169 | 0.185 | 0.895 | 0.283 |
CYP3A4-Inhibitor | 0.187 | 0.098 | 0.674 | 0.697 |
CYP3A4-Substrate | 0.025 | 0.106 | 0.517 | 0.08 |
CL | 7.716 | 16.556 | 13.839 | 6.868 |
T12 | 0.945 | 0.928 | 0.948 | 0.905 |
hERG | 0.145 | 0.102 | 0.214 | 0.07 |
H-HT | 0.099 | 0.235 | 0.475 | 0.098 |
DILI | 0.982 | 0.905 | 0.895 | 0.979 |
Ames | 0.482 | 0.153 | 0.234 | 0.672 |
ROA | 0.022 | 0.032 | 0.896 | 0.156 |
FDAMDD | 0.557 | 0.113 | 0.776 | 0.109 |
SkinSen | 0.943 | 0.971 | 0.958 | 0.856 |
Carcinogenicity | 0.028 | 0.023 | 0.706 | 0.097 |
EC | 0.008 | 0.003 | 0.007 | 0.009 |
EI | 0.93 | 0.933 | 0.792 | 0.929 |
Respiratory | 0.065 | 0.02 | 0.951 | 0.09 |
BCF | 0.939 | 0.974 | 0.8 | 0.986 |
IGC50 | 3.885 | 4.154 | 5.077 | 4.386 |
LC50 | 4.982 | 5.144 | 6.191 | 5.223 |
LC50DM | 5.272 | 5.596 | 5.194 | 5.205 |
NR-AR | 0.006 | 0.006 | 0.807 | 0.008 |
NR-AR-LBD | 0.152 | 0.087 | 0.787 | 0.371 |
NR-AhR | 0.968 | 0.782 | 0.596 | 0.967 |
NR-Aromatase | 0.889 | 0.691 | 0.619 | 0.941 |
NR-ER | 0.918 | 0.846 | 0.6 | 0.959 |
NR-ER-LBD | 0.985 | 0.991 | 0.624 | 0.985 |
NR-PPAR-gamma | 0.954 | 0.865 | 0.957 | 0.963 |
SR-ARE | 0.769 | 0.561 | 0.891 | 0.873 |
SR-ATAD5 | 0.292 | 0.109 | 0.647 | 0.612 |
SR-HSE | 0.535 | 0.941 | 0.884 | 0.557 |
SR-MMP | 0.962 | 0.968 | 0.871 | 0.968 |
SR-p53 | 0.903 | 0.712 | 0.906 | 0.921 |
MW | 318.04 | 458.08 | 368.13 | 286.05 |
Vol | 291.557 | 425.17 | 381.036 | 273.977 |
Dense | 1.091 | 1.077 | 0.966 | 1.044 |
nHA | 8 | 11 | 6 | 6 |
nHD | 6 | 8 | 2 | 4 |
TPSA | 151.59 | 197.37 | 93.06 | 111.13 |
nRot | 1 | 4 | 8 | 1 |
nRing | 3 | 4 | 2 | 3 |
MaxRing | 10 | 10 | 6 | 10 |
nHet | 8 | 11 | 6 | 6 |
fChar | 0 | 0 | 0 | 0 |
nRig | 18 | 24 | 16 | 18 |
Flex | 0.056 | 0.167 | 0.5 | 0.056 |
nStereo | 0 | 2 | 0 | 0 |
NonGenotoxic_Carcinogenicity | 0 | 0 | 1 | 0 |
LD50_oral | 0 | 0 | 0 | 0 |
Genotoxic_Carcinogenicity_Mutagenicity | 0 | 0 | 1 | 0 |
SureChEMBL | 1 | 1 | 0 | 0 |
NonBiodegradable | 1 | 1 | 1 | 1 |
Skin_Sensitization | 8 | 9 | 8 | 4 |
Acute_Aquatic_Toxicity | 0 | 0 | 2 | 0 |
Toxicophores | 2 | 2 | 3 | 1 |
QED | 0.371 | 0.212 | 0.548 | 0.546 |
Synth | 2.733 | 3.74 | 2.426 | 2.375 |
Fsp3 | 0 | 0.136 | 0.143 | 0 |
MCE-18 | 20 | 87.48 | 14 | 18 |
Natural Product-likeness | 1.698 | 1.65 | 0.722 | 1.546 |
Alarm_NMR | 3 | 3 | 3 | 2 |
BMS | 1 | 1 | 0 | 0 |
Chelating | 2 | 1 | 2 | 1 |
PAINS | 1 | 1 | 0 | 0 |
Lipinski | Accepted | Rejected | Accepted | Accepted |
Pfizer | Accepted | Accepted | Accepted | Accepted |
GSK | Accepted | Rejected | Accepted | Accepted |
GoldenTriangle | Accepted | Accepted | Accepted | Accepted |